After Setbacks, Confidence Grows In Likely Success For Sarepta’s Duchenne Gene Therapy
Contrasts With Pfizer Safety Concerns
The latest Phase II readout adds to growing data suggesting Sarepta's gene therapy could prove safe and effective. • Source: Alamy 
